Clinical Trial Imaging

Invicro’s clinical imaging capabilities span from early phase, first-in-human through late phase and post-approval studies. We focus on studies containing imaging-based endpoints requiring robust, independent assessments to ascertain drug efficacy.

Our late phase imaging solutions support various therapeutic areas including oncology, neurology (CNS), cardiovascular, musculoskeletal and gastrointestinal. Our experience comes from years of successful execution of Phase II-IV studies across the development spectrum led by a leadership team with an average of 25 years of industry experience.

Contact us

Modalities

Invicro supports all imaging modalities to identify anatomical and metabolic markers of disease, drug effects and safety signals.

  • CT
  • MRI
  • PET
  • SPECT
  • NM bone scan
  • Echo
  • X-ray
  • Photography
  • Ultrasound